首页> 美国卫生研究院文献>World Journal of Oncology >Clinical Characteristics and Outcome Trends of Adjuvant Anthracycline and Taxane Regimen for Early Stage Breast Cancer

【2h】

Clinical Characteristics and Outcome Trends of Adjuvant Anthracycline and Taxane Regimen for Early Stage Breast Cancer

机译：早期乳腺癌辅助用蒽环类和紫杉烷类药物治疗的临床特点和结果趋势

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

The anthracycline and taxane-based chemotherapy treatment regimen remains the gold standard for treatment of early stage breast cancer. However, studies examining the effectiveness and use of this treatment regimen in Indian context are limited. This study examined patients treated with anthracycline and taxane-based chemotherapy at a tertiary care cancer center in India.

机译：蒽环类和紫杉烷类化疗方案仍然是治疗早期乳腺癌的金标准。然而，在印度背景下研究这种治疗方案的有效性和使用的研究是有限的。这项研究检查了印度三级癌症中心接受蒽环类和紫杉烷类化学疗法治疗的患者。

著录项

期刊名称 World Journal of Oncology
作者
Ashok K. Vaid; Aseem Khurana; Devender Sharma; Dheeraj Gautam; Jyoti Wadhwa; Rajiv Agarwal; Kanchan Kaur; Jyoti Arora; Kush Gupta;
展开▼
作者单位

展开▼
年(卷),期 2020(11),3
年度 2020
页码 -1
总页数 6
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词
Anthracycline; Taxane; Early breast cancer; Adjuvant chemotherapy;

机译：蒽环类;紫杉烷;早期乳腺癌;辅助化疗;

相似文献

外文文献
中文文献
专利

1. Clinical Characteristics and Outcome Trends of Adjuvant Anthracycline and Taxane Regimen for Early Stage Breast Cancer [J] . Ashok K. Vaid, Aseem Khurana, Devender Sharma, World Journal of Oncology . 2020,第3期

机译：早期乳腺癌辅助蒽环素和紫杉烷方案的临床特征及结果趋势
2. Classical CMF regimen as adjuvant chemotherapy for triple-negative breast cancer may be more effective compared with anthracycline or taxane-based regimens. [J] . Shusen Wang, Yanxia Shi, Zhongyu Yuan, Medical oncology . 2012,第2期

机译：与基于蒽环类或紫杉烷类的方案相比，经典的CMF方案作为三阴性乳腺癌的辅助化疗方案可能更有效。
3. Comparison of EQ-5D scores among anthracycline-containing regimens followed by taxane and taxane-only regimens for node-positive breast cancer patients after surgery: The N-SAS BC 02 trial [J] . ShiroiwaT., FukudaT., ShimozumaK., Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research . 2011,第5期

机译：N-SAS BC 02试验对淋巴结阳性乳腺癌患者术后采用含蒽环类药物的方案后采用紫杉类和仅使用紫杉类方案的EQ-5D评分的比较
4. Clinical implications of HER-2 and p53 in taxane-based and anthracycline-based neoadjuvant chemotherapy in breast cancer [C] . World congress on breast diseases . 2008

机译：HER-2和P53在紫杉烷基和蒽环类新辅助化疗的乳腺癌中的临床意义
5. The genomic response of MCF-7 breast cancer cells in the selection of resistance to taxane and anthracycline chemotherapeutics. [D] . Veitch, Zachary William Neil. 2007

机译：MCF-7乳腺癌细胞在对紫杉烷和蒽环类药物的耐药性选择中的基因组反应。
6. Weekly taxane–anthracycline combination regimen versus tri-weekly anthracycline-based regimen for the treatment of locally advanced breast cancer: a randomized controlled trial [O] . Qiu-Wen Tan, Ting Luo, Hong Zheng, 2017

机译：每周紫杉烷-蒽环类药物联合方案与三周基于蒽环类药物的方案治疗局部晚期乳腺癌的随机对照试验
7. Comparison of EQ-5D Scores among Anthracycline-Containing Regimens followed by Taxane and Taxane-Only Regimens for Node-Positive Breast Cancer Patients after Surgery: The N-SAS BC 02 Trial [O] . Shiroiwa Takeru, Fukuda Takashi, Shimozuma Kojiro, 2011

机译：手术后淋巴结阳性的乳腺癌患者中，含蒽环类治疗方案，紫杉类和仅紫杉类治疗方案之间的EQ-5D得分比较：N-SAS BC 02试验

Clinical Characteristics and Outcome Trends of Adjuvant Anthracycline and Taxane Regimen for Early Stage Breast Cancer

摘要

著录项

相似文献

相关主题

期刊订阅